Abstract
Among the current molecular pharming approaches, seed-based expression offers particular advantages as heterologous proteins can be produced at high levels in a highly stable biomass that can also serve as an oral vaccine after either minimal or no processing. Therefore, seeds can be readily used as platforms for the production of low-cost vaccines that are environmentally friendly and easy to administer. In this chapter, various strategies that address expression of immunogens in seeds are presented. Seed-based approaches that have been undertaken to develop candidate vaccines against cholera, malaria, hepatitis B, and diarrhea are featured as examples of the promising potential of these approaches. Moreover, insights into the immunogenic properties of seed-based candidate vaccines are explored. In addition, efforts that prevent undesirable gene flow and release of transgene(s) into the environment are also explored.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bhatla SC, Kaushik V, Yadav MK (2010) Use of oil bodies and oleosins in recombinant protein production and other biotechnological applications. Biotechnol Adv 28:293–300
Boothe JG, Saponja JA, Parmenter DL (1997) Molecular farming in plants: oilseeds as vehicles for the production of pharmaceutical proteins. Drug Dev Res 42:172–181
Capuano F, Beaudoin F, Napier JA, Shewry PR (2007) Properties and exploitation of oleosins. Biotechnol Adv 25:203–206
Chikwamba R, Cunnick J, Hathaway D, McMurray J, Mason H, Wang K (2002) A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Res 5:479–493
Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6:219–226
Deckers HM, van Rooijen G, Boothe J, Goll J, Moloney MM, Schryvers AB, Alcantara J, Hutchins WA (2004) Immunogenic formulations comprising oil bodies. U.S. Patent 6761914 B2
Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7:152–158
Food and Agriculture Organization of the United Nations (2013) www.fao.org. Accessed 15 Jan 2014
Garg R, Tolbert M, Oakes JL, Clemente TE, Bost KL, Piller KJ (2007) Chloroplast targeting of FanC, the major antigenic subunit of Escherichia coli K99 fimbriae, in transgenic soybean. Plant Cell Rep 26:1011–1023
Goossens A, Van Montagu M, Angenon G (1999) Co-introduction of an antisense gene for an endogenous seed storage protein can increase expression of a transgene in Arabidopsis thaliana seeds. FEBS Lett 456:160–164
Haq TA, Mason HS, Clements JD, Arntzen CJ (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268:714–716
Hayden CA, Egelkrout EM, Moscoso AM, Enrique C, Keener TK, Jimenez-Flores R, Wong JC, Howard JA (2012) Production of highly concentrated, heat-stable hepatitis B surface antigen in maize. Plant Biotechnol J 10:979–984
Hills MJ, Hall L, Arnison PG, Good AG (2007) Genetic use restriction technologies (GURTs): strategies to impede transgene movement. Trends Plant Sci 12:177–183
Hood EE, Kusnadi A, Nikolov Z, Howard JA (1999) Molecular farming of industrial proteins from transgenic maize. Adv Exp Med Biol 464:127–147
Huang AHC (1992) Oil bodies and oleosins in seeds. Annu Rev Plant Physiol Plant Mol Biol 43:177–200
Hudson LC, Seabolt BS, Odle J, Bost KL, Stahl CH, Piller KJ (2013) Sublethal staphylococcal enterotoxin B challenge model in pigs to evaluate protection following immunization with a soybean-derived vaccine. Clin Vaccine Immunol 20:24–32
Karaman S, Cunnick J, Wang K (2012) Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler’s diarrhea. Plant Cell Rep 31:527–537
Karg SR, Kallio PT (2009) The production of biopharmaceuticals in plant systems. Biotechnol Adv 27:879–894
Khan I, Twyman RM, Arcalis E, Stoger E (2012) Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol J 7:1–11
Kuvshinov V, Koivu K, Kanerva A, Pehu E (2001) Molecular control of transgene escape from genetically modified plants. Plant Sci 160:517–522
Lamphear BJ, Streatfield SJ, Jilka JM, Brooks CA, Barker DK, Turner DD, Delaney DE, Garcia M, Wiggins B, Woodard SL, Hood EE, Tizard IR, Lawhorn B, Howard JA (2002) Delivery of subunit vaccines in maize seed. J Control Release 85:169–180
Lamphear BJ, Jilka JM, Kesl L, Welter M, Howard JA, Streatfield SJ (2004) A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22:2420–2424
Lau O, Ng D, Chan W, Chang S, Sun S (2010) Production of the 42-kDa fragment of Plasmodium falciparum merozoite surface protein 1, a leading malaria vaccine antigen, in Arabidopsis thaliana seeds. Plant Biotechnol J 8:994–1004
Mason HS, Lam DM, Arntzen CJ (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci. USA, 89:11745–11749
Ma J, Drake P, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805
Mihaliak CA, Webb S, Miller T, Fanton M, Kirk D, Cardineau G, Mason H, Walmsley A, Arntzen C, van Eck J (2005) Development of plant cell produced vaccines for animal health applications. In: Proceedings of the 108th annual meeting of the United States Animal Health Association, Greensboro, NC, USA, pp 158–163
Moravec T, Schmidt MA, Herman EM, Woodford-Thomas T (2007) Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. Vaccine 25:1647–1657
Muntz K (1998) Deposition of storage proteins. Plant Mol Biol 38:77–99
Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci USA 104:10986–10991
Nojima J, Ishii-Katsuno R, Futai E, Sasagawa N, Watanabe Y, Yoshida T, Ishiura S (2011) Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β. Biosci Biotechnol Biochem 75:396–400
Nykiforuk CL, Boothe JG, Murray EW, Keon RG, Goren J, Markley NA, Moloney MM (2006) Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 4:77–85
Oszvald M, Kang T, Tomoskozi S, Jenes B, Kim T, Cha Y, Tamas L, Yang M (2008) Expression of cholera toxin B subunit in transgenic rice endosperm. Mol Biotechnol 40:261–268
Parmenter DL, Boothe JG, van Rooijen GJH, Yeung EC, Moloney MM (1995) Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant Mol Biol 29:1167–1180
Piller KJ, Clemente TE, Jun SM, Petty CC, Sato S, Pascual DW, Bost KL (2005) Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean. Planta 222:6–18
Qian B, Shen H, Liang W, Guo X, Zhang C, Wang Y, Li G, Wu A, Cao K, Zhang D (2008) Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds. Transgenic Res 17:621–631
Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solís AG (2008) Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 27:79–84
Schmidt SR (2013) Protein bodies in nature and biotechnology. Mol Biotechnol 54:257–268
Stoger E, Vaquero C, Torres E, Sack M, Nicholson L, Drossard J, Williams S, Keen D, Perrin Y, Christou P, Fischer R (2000) Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol Biol 42:583–590
Stoger E, Ma J, Fischer R, Christou P (2005) Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 16:167–173
Streatfield SJ (2006) Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150–157
Streatfield SJ, Howard JA (2003) Plant-based vaccines. Int J Parasitol 33:479–493
Streatfield SJ, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, Woodard SL, Beifuss KK, Horn ME, Delaney DE, Tizard IR, Howard JA (2001) Plant-based vaccines: unique advantages. Vaccine 19:2742–2748
Streatfield SJ, Lane JR, Brooks CA, Barker DK, Poage ML, Mayor JM, Lamphear BJ, Drees CF, Jilka JM, Hood EE, Howard JA (2003) Corn as a production system for human and animal vaccines. Vaccine 21:812–815
Tackaberry ES, Dudani AK, Prior F, Tocchi M, Sardana R, Altosaar I, Ganz PR (1999) Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco. Vaccine 17:3020–3029
Tackaberry ES, Prior F, Bell M, Tocchi M, Porter S, Mehic J, Ganz PR, Sardana R, Altosaar I, Dudani A (2003) Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Genome 46:521–526
Tackaberry ES, Prior FA, Rowlandson K, Tocchi M, Mehic J, Porter S, Walsh M, Schleiss MR, Ganz PR, Sardana RK, Altosaar I, Dudani AK (2008) Sustained expression of human cytomegalovirus glycoprotein B (UL55) in the seeds of homozygous rice plants. Mol Biotechnol 40:1–12
Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in transgenic potato. Nat Med 4:607–609
Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302–305
Tacket CO, Pasetti MF, Edelman R, Howard JA, Streatfield S (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine 22:4385–4389
Takagi H, Saito S, Yang L, Nagasaka S, Nishizawa N, Takaiwa F (2005) Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine. Plant Biotechnol J 3:521–533
Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N, Goodwin P, Arntzen CJ, Mason HS (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci U S A 102:3378–3382
Tiwari S, Verma PC, Singh PK, Tuli R (2009) Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 27:449–467
Vimolmangkang V, Gasic K, Soria-Guerra R, Rosales-Mendoza S, Moreno-Fierros L, Korban SS (2012) Expression of the nucleocapsid protein of porcine reproductive and respiratory syndrome virus (PRRSV) in soybean seed yields an immunogenic antigenic protein. Planta 235:3513–522
Wang Y, Deng H, Zhang X, Xiao H, Jiang Y, Song Y, Fang L, Xiao S, Zhen Y, Chen H (2009) Generation and immunogenicity of Japanese encephalitis virus envelope protein expressed in transgenic rice. Biochem Biophys Res Commun 380:292–297
Wang S, Takahashi H, Kajiura H, Kawakatsu T, Fujiyama K, Takaiwa F (2013) Transgenic rice seeds accumulating recombinant hypoallergenic birch pollen allergen Bet v 1 generate giant protein bodies. Plant Cell Physiol 54:917–933
Wright KE, Prior F, Sardana R, Altosaar I, Dudani AK, Ganz PR, Tackaberry ES (2001) Sorting of glycoprotein B from human cytomegalovirus to protein storage vesicles in seeds of transgenic tobacco. Transgenic Res 10:177–181
Wu J, Yu L, Li L, Hu J, Zhou J, Zhou X (2007) Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 5:570–578
Yang C, Chen S, Duan G (2011) Transgenic peanut (Arachis hypogaea L.) expressing the urease subunit B gene of Helicobacter pylori. Curr Microbiol 63:387–391
Yang L, Hirose S, Suzuki K, Hiroi T, Takaiwa F (2012) Expression of hypoallergenic Der f 2 derivatives with altered intramolecular disulphide bonds induces the formation of novel ER-derived protein bodies in transgenic rice seeds. J Exp Bot 63:2947–2959
Yuki Y, Mejima M, Kurokawa S, Hiroiwa T, Kong IG, Kuroda M, Takahashi Y, Nochi T, Tokuhara D, Kohda T, Kozaki S, Kiyono H (2012) RNAi suppression of rice endogenous storage proteins enhances the production of rice-based Botulinum neurotoxin type A vaccine. Vaccine 30:4160–4166
Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 7:313–321
Zhang X, Yuan Z, Guo X, Li J, Li Z, Wang Q (2008) Expression of Chlamydophila psittaci MOMP heat-labile toxin B subunit fusion gene in transgenic rice. Biologicals 36:296–302
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Orellana-Escobedo, L., Korban, S., Rosales-Mendoza, S. (2014). Seed-Based Expression Strategies. In: Rosales-Mendoza, S. (eds) Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0850-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0850-9_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0849-3
Online ISBN: 978-1-4939-0850-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)